Results 1 to 10 of about 2,152,109 (243)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy [PDF]

open access: yesOphthalmology Science, 2023
Purpose: To examine whether patients with diabetic retinopathy receiving intravitreal anti-VEGF injections are at increased risk of kidney function decline. Design: Retrospective cohort study. Participants: Included 187 patients who received intravitreal
Casey C. Bunge, MD   +7 more
doaj   +5 more sources

Association of Anti-VEGF Injections with Progression of Geographic Atrophy [PDF]

open access: yesOphthalmology and Eye Diseases, 2016
Age-related macular degeneration (AMD) is one of the leading causes of blindness in developed countries in people over the age of 60 years. One of the forms of advanced AMD is wet AMD.
Ryan Enslow   +5 more
doaj   +4 more sources

Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology [PDF]

open access: yesEpidemiology and Health, 2021
OBJECTIVES The aim of this study was to evaluate the real-world incidence of endophthalmitis after intravitreal anti-vascular endothelial growth factor (VEGF) injections using data from the Observational Medical Outcomes Partnership (OMOP) Common Data ...
Yongseok Mun   +15 more
doaj   +6 more sources

Real-World Outcomes in Patients with Branch Retinal Vein Occlusion- (BRVO-) Related Macular Edema Treated with Anti-VEGF Injections Alone versus Anti-VEGF Injections Combined with Focal Laser [PDF]

open access: yesJournal of Ophthalmology, 2021
The purpose of this study was to assess outcomes in a real-world nonclinical trial setting of antivascular endothelial growth factor (VEGF) injections alone vs. focal laser combined with anti-VEGF injections in patients with branch retinal vein occlusion-
Meredith E. Thomley   +6 more
doaj   +3 more sources

Comparative incidence of endophthalmitis after intravitreal dexamethasone implant versus anti-VEGF injections: a retrospective study [PDF]

open access: yesInternational Journal of Retina and Vitreous
Background Endophthalmitis is a rare but vision-threatening complication of intravitreal injections. Intravitreal dexamethasone implants and anti–vascular endothelial growth factor (anti-VEGF) agents are widely used, yet comparative real-world ...
Iza D. Zabaneh   +3 more
doaj   +2 more sources

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks [PDF]

open access: yesJournal of Ophthalmology, 2022
Purpose. This study aimed to evaluate the long-term effectiveness of intravitreal anti-vascular endothelial growth factor (VEGF) injections in the treatment of choroidal neovascularization (CNV) associated with angioid streaks. Methods.
Sónia Torres-Costa   +11 more
doaj   +2 more sources

Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion

open access: yesJournal of Ophthalmology, 2021
Purpose. To evaluate whether treatment with intravitreal corticosteroid and anti-vascular endothelial growth factor (VEGF) injections alternately can improve treatment outcomes of macular edema (ME) caused by retinal vein occlusion (RVO). Methods.
Young Hwan Bae   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy